INTC
41
5
BIIB
37
9
MPC
28
2
UNP
42
-4
HCA
50
2
NAVI
43
16
PSX
34
4
LNC
39
-6
JNJ
42
-2
MAC
67
2
COST
50
2
GWW
64
-3
FSLR
63
6
BEN
33
-5
AAP
30
3
EXR
48
2
DGX
33
-6
NWSA
73
15
KEY
33
-4
HES
62
4
INTC
41
5
BIIB
37
9
MPC
28
2
UNP
42
-4
HCA
50
2
NAVI
43
16
PSX
34
4
LNC
39
-6
JNJ
42
-2
MAC
67
2
COST
50
2
GWW
64
-3
FSLR
63
6
BEN
33
-5
AAP
30
3
EXR
48
2
DGX
33
-6
NWSA
73
15
KEY
33
-4
HES
62
4
Financhill
Back

abrdn Life Sciences Investors Vs. Viking Therapeutics Industry Stock Comparison

Sell
29

HQL
abrdn Life Sciences Investors

Last Price:
14.90
Seasonality Move:
6.15%
Sell
45

VKTX
Viking Therapeutics

Last Price:
64.63
Seasonality Move:
38.04%
Sell
29
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors a Buy, Sell or Hold?

  • The current abrdn Life Sciences Investors [HQL] share price is $14.71. The Score for HQL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HQL Stock Price Chart

What is abrdn Life Sciences Investors's stock price today?

  • The abrdn Life Sciences Investors share price today is $14.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing slight buying pressure.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $63.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

HQL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 40.94 Sell
Chaikin Money Flow: 3038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.78 - 15.08) Sell
Bollinger Bands (100): (14.47 - 15.43) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.92 Buy
Relative Strength Index (14 RSI): 44.37 Sell
Chaikin Money Flow: -27799915 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.04 - 71.46) Sell
Bollinger Bands (100): (52.9 - 66.58) Buy

HQL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.81 Sell
20-day SMA: 14.93 Sell
50-day SMA: 15.04 Sell
200-day SMA: 14.28 Buy
8-day EMA: 14.79 Sell
20-day EMA: 14.9 Sell
50-day EMA: 14.97 Sell
200-day EMA: 14.42 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.43 Sell
20-day SMA: 67.48 Sell
50-day SMA: 64.43 Sell
200-day SMA: 59.82 Buy
8-day EMA: 69.69 Sell
20-day EMA: 68.14 Sell
50-day EMA: 65.07 Sell
200-day EMA: 55.33 Buy

abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.

abrdn Life Sciences Investors Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):